Assessment of non-palpable mammographic abnormalities: comparison between screening and symptomatic clinics.
A retrospective study found that a breast screening clinic generated fewer localization biopsies for non-palpable mammographic abnormalities than a symptomatic clinic (3.36 versus 9.89 per 1000 mammograms, respectively) and that a greater proportion of such biopsies were malignant. This study determined the reason for this difference. There were 108 of 304 (35.5 per cent) and 17 of 130 (13.1 per cent) carcinomas in women attending the screening and breast clinics respectively (relative risk 2.72 (95 per cent confidence interval 1.70-4.34)). This difference was regardless of age. The characteristics of the mammographic abnormality, the Wolfe pattern, a family history of breast carcinoma, parity and age at first pregnancy were similar in both groups. Women attending the screening clinic were referred for localization biopsy after assessment by clinicians and radiologists at a joint clinic; there was no joint assessment for patients attending the breast clinic. The same staff attended both clinics, although the proportion of time spent at each varied. This study suggests that all women with a non-palpable mammographic abnormality should be reviewed at a joint assessment clinic before localization biopsy is recommended.
Aitken
R J
RJ
University Department of Surgery, University of Edinburgh, UK.
Forrest
A P
AP
Chetty
U
U
Roberts
M M
MM
Huggins
A
A
MacDonald
H L
HL
Muir
B B
BB
Kirkpatrick
A E
AE
Anderson
T J
TJ
D001706:Biopsy / Q000706:statistics & numerical data; D001940:Breast / Q000473:pathology*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology*; D005260:Female; D006801:Humans; D008327:Mammography; D008403:Mass Screening / Q000379:methods; D012017:Referral and Consultation; D012189:Retrospective Studies; D012307:Risk Factors